The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05011279
Recruitment Status : Completed
First Posted : August 18, 2021
Results First Posted : May 8, 2023
Last Update Posted : November 15, 2023
Sponsor:
Collaborators:
University of Massachusetts, Boston
University of Rochester
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Catherine Marinac, PhD, Dana-Farber Cancer Institute

Study Type Interventional
Study Design Allocation: N/A;   Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Supportive Care
Conditions Breast Cancer Survivor
Breast Cancer
Fitness Trackers
Intervention Other: Move Together app/Garmin Activity Tracker
Enrollment 10
Recruitment Details  
Pre-assignment Details  
Arm/Group Title Pilot Study
Hide Arm/Group Description

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads) in this single arm study. One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Period Title: Overall Study
Started 10 [1]
Completed 10 [1]
Not Completed 0
[1]
5 survivors and 5 relatives
Arm/Group Title Pilot Study
Hide Arm/Group Description

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Baseline Participants 10
Hide Baseline Analysis Population Description
this includes 5 survivors and 5 relatives
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 10 participants
<=18 years
0
   0.0%
Between 18 and 65 years
8
  80.0%
>=65 years
2
  20.0%
Age, Continuous  
Mean (Full Range)
Unit of measure:  Years
Number Analyzed 10 participants
45.9
(22 to 70)
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 10 participants
Female
10
 100.0%
Male
0
   0.0%
Race (NIH/OMB)  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 10 participants
American Indian or Alaska Native
0
   0.0%
Asian
0
   0.0%
Native Hawaiian or Other Pacific Islander
0
   0.0%
Black or African American
10
 100.0%
White
0
   0.0%
More than one race
0
   0.0%
Unknown or Not Reported
0
   0.0%
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
United States Number Analyzed 10 participants
10
Breast Cancer Status  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 10 participants
Survivor
5
  50.0%
Mother of a survivor, no BRCA
1
  10.0%
Daughter of a survivor, no BRCA
1
  10.0%
Sister of a survivor, no BRCA
2
  20.0%
Niece of a survivor, no BRCA
1
  10.0%
1.Primary Outcome
Title System Usability Scale (SUS) Score
Hide Description The acceptability of the Move Together app will also be assessed with The System Usability Scale (SUS) score. The scale has 10 items. Scores range from 0-100; a SUS score above a 68 is considered above average (https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html.)
Time Frame Assessed at 4 Weeks
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Mean (Standard Deviation)
Unit of Measure: units on a scale
72  (14.3)
2.Secondary Outcome
Title Number of Participants Screened Per Month
Hide Description the number of participants screened per month during recruitment period (not cumulative)
Time Frame 4 month recruitment period
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Measure Type: Count of Participants
Unit of Measure: Participants
5
  50.0%
3.Secondary Outcome
Title Number of Participants Enrolled Per Month
Hide Description number of participants consented to the study each month during enrollment period
Time Frame 4 month enrollment period
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Measure Type: Count of Participants
Unit of Measure: Participants
3
  30.0%
4.Secondary Outcome
Title Completion Rate
Hide Description number of participants who completed all aspects of the protocol
Time Frame 4 Weeks
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Measure Type: Count of Participants
Unit of Measure: Participants
10
 100.0%
5.Secondary Outcome
Title Number of Study Days
Hide Description number of study days in which the participants uses the Move Together app and will describe engagement with the app in a 28 day period (i.e., study days)
Time Frame baseline to 4 weeks (28 days)
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Mean (Standard Deviation)
Unit of Measure: days
17.1  (8.6)
6.Secondary Outcome
Title Number of Participants Recruited
Hide Description Number of initial respondents who consent and enroll.
Time Frame during 4 month recruitment period
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Measure Type: Number
Unit of Measure: participants
1
7.Secondary Outcome
Title Number of Participants Completed Study
Hide Description Total number of participants who completed the study
Time Frame 4 weeks
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Measure Type: Number
Unit of Measure: number of participants
9
8.Secondary Outcome
Title Number of Participants Retained at the End of 4 Weeks
Hide Description Retention will be the number who remain in the study at the end of 4 weeks
Time Frame Baseline to 4 Weeks
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Pilot Study
Hide Arm/Group Description:

Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Overall Number of Participants Analyzed 10
Measure Type: Number
Unit of Measure: number of participants
10
Time Frame 5 weeks
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title Single Arm of Breast Cancer Survivors (n=5) and Family Members (n=5)
Hide Arm/Group Description

Participants in the single arm pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative.

Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links.

-Garmin activity tracker in this study is for participants to track their steps and sedentary time.

All-Cause Mortality
Single Arm of Breast Cancer Survivors (n=5) and Family Members (n=5)
Affected / at Risk (%)
Total   0/10 (0.00%) 
Hide Serious Adverse Events
Single Arm of Breast Cancer Survivors (n=5) and Family Members (n=5)
Affected / at Risk (%)
Total   0/10 (0.00%) 
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
Single Arm of Breast Cancer Survivors (n=5) and Family Members (n=5)
Affected / at Risk (%)
Total   0/10 (0.00%) 
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Catherine Marinac
Organization: Dana-Farber Cancer Institute
Phone: 617-632-4703
EMail: CatherineR_Marinac@dfci.harvard.edu
Layout table for additonal information
Responsible Party: Catherine Marinac, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier: NCT05011279    
Other Study ID Numbers: 20-104
U54CA156732 ( U.S. NIH Grant/Contract )
First Submitted: August 13, 2021
First Posted: August 18, 2021
Results First Submitted: December 28, 2022
Results First Posted: May 8, 2023
Last Update Posted: November 15, 2023